These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

365 related items for PubMed ID: 15487901

  • 1. Interaction of oxaliplatin, cisplatin, and carboplatin with hemoglobin and the resulting release of a heme group.
    Mandal R, Kalke R, Li XF.
    Chem Res Toxicol; 2004 Oct; 17(10):1391-7. PubMed ID: 15487901
    [Abstract] [Full Text] [Related]

  • 2. Mass spectrometric studies of cisplatin-induced changes of hemoglobin.
    Mandal R, Kalke R, Li XF.
    Rapid Commun Mass Spectrom; 2003 Oct; 17(24):2748-54. PubMed ID: 14673822
    [Abstract] [Full Text] [Related]

  • 3. Mass spectrometry study of hemoglobin-oxaliplatin complexes in colorectal cancer patients and potential association with chemotherapeutic responses.
    Mandal R, Sawyer MB, Li XF.
    Rapid Commun Mass Spectrom; 2006 Oct; 20(17):2533-8. PubMed ID: 16878345
    [Abstract] [Full Text] [Related]

  • 4. Analysis of cytotoxicities of platinum compounds.
    Goodisman J, Hagrman D, Tacka KA, Souid AK.
    Cancer Chemother Pharmacol; 2006 Jan; 57(2):257-67. PubMed ID: 16028101
    [Abstract] [Full Text] [Related]

  • 5. The interaction of platinum-based drugs with native biologically relevant proteins.
    Brauckmann C, Wehe CA, Kieshauer M, Lanvers-Kaminsky C, Sperling M, Karst U.
    Anal Bioanal Chem; 2013 Feb; 405(6):1855-64. PubMed ID: 23052861
    [Abstract] [Full Text] [Related]

  • 6. ESI mass spectrometry and X-ray diffraction studies of adducts between anticancer platinum drugs and hen egg white lysozyme.
    Casini A, Mastrobuoni G, Temperini C, Gabbiani C, Francese S, Moneti G, Supuran CT, Scozzafava A, Messori L.
    Chem Commun (Camb); 2007 Jan 14; (2):156-8. PubMed ID: 17180231
    [Abstract] [Full Text] [Related]

  • 7. Kinetic study on the reactions of platinum drugs with glutathione.
    Hagrman D, Goodisman J, Souid AK.
    J Pharmacol Exp Ther; 2004 Feb 14; 308(2):658-66. PubMed ID: 14610218
    [Abstract] [Full Text] [Related]

  • 8. In vitro cytotoxicity, protein binding, red blood cell partitioning, and biotransformation of oxaliplatin.
    Pendyala L, Creaven PJ.
    Cancer Res; 1993 Dec 15; 53(24):5970-6. PubMed ID: 8261411
    [Abstract] [Full Text] [Related]

  • 9. Inductively coupled plasma mass spectroscopy quantitation of platinum-DNA adducts in peripheral blood leukocytes of patients receiving cisplatin- or carboplatin-based chemotherapy.
    Bonetti A, Apostoli P, Zaninelli M, Pavanel F, Colombatti M, Cetto GL, Franceschi T, Sperotto L, Leone R.
    Clin Cancer Res; 1996 Nov 15; 2(11):1829-35. PubMed ID: 9816137
    [Abstract] [Full Text] [Related]

  • 10. TCEP-based rSDS-PAGE AND nLC-ESI-LTQ-MS/MS for oxaliplatin metalloproteomic analysis.
    Mena ML, Moreno-Gordaliza E, Gómez-Gómez MM.
    Talanta; 2013 Nov 15; 116():581-92. PubMed ID: 24148449
    [Abstract] [Full Text] [Related]

  • 11. Analysis of major protein-protein and protein-metal complexes of erythrocytes directly from cell lysate utilizing capillary electrophoresis mass spectrometry.
    Nguyen A, Moini M.
    Anal Chem; 2008 Sep 15; 80(18):7169-73. PubMed ID: 18710259
    [Abstract] [Full Text] [Related]

  • 12. Experimental study of renal disorder caused by oxaliplatin in rat renal cortical slices.
    Kanou T, Uozumi J, Soejima K, Tokuda Y, Masaki Z.
    Clin Exp Nephrol; 2004 Dec 15; 8(4):310-5. PubMed ID: 15619029
    [Abstract] [Full Text] [Related]

  • 13. Early biotransformations of oxaliplatin after its intravenous administration to cancer patients.
    Allain P, Heudi O, Cailleux A, Le Bouil A, Larra F, Boisdron-Celle M, Gamelin E.
    Drug Metab Dispos; 2000 Nov 15; 28(11):1379-84. PubMed ID: 11038167
    [Abstract] [Full Text] [Related]

  • 14. Quantitative measurement of the reduction of platinum(IV) complexes using X-ray absorption near-edge spectroscopy (XANES).
    Hall MD, Daly HL, Zhang JZ, Zhang M, Alderden RA, Pursche D, Foran GJ, Hambley TW.
    Metallomics; 2012 Jun 15; 4(6):568-75. PubMed ID: 22569908
    [Abstract] [Full Text] [Related]

  • 15. Sensitive detection of DNA modifications induced by cisplatin and carboplatin in vitro and in vivo using a monoclonal antibody.
    Tilby MJ, Johnson C, Knox RJ, Cordell J, Roberts JJ, Dean CJ.
    Cancer Res; 1991 Jan 01; 51(1):123-9. PubMed ID: 1703029
    [Abstract] [Full Text] [Related]

  • 16. Investigation of interaction between human hemoglobin A0 and platinum anticancer drugs by capillary isoelectric focusing with whole column imaging detection.
    Lemma T, Mandal R, Li XF, Pawliszyn J.
    J Sep Sci; 2008 Jun 01; 31(10):1803-9. PubMed ID: 18446809
    [Abstract] [Full Text] [Related]

  • 17. Glutathione modified CdTe quantum dots as a label for studying DNA interactions with platinum based cytostatics.
    Ryvolova M, Smerkova K, Chomoucka J, Hubalek J, Adam V, Kizek R.
    Electrophoresis; 2013 Mar 01; 34(6):801-8. PubMed ID: 23400813
    [Abstract] [Full Text] [Related]

  • 18. Intact human holo-transferrin interaction with oxaliplatin.
    Zhao YY, Mandal R, Li XF.
    Rapid Commun Mass Spectrom; 2005 Mar 01; 19(14):1956-62. PubMed ID: 15954173
    [Abstract] [Full Text] [Related]

  • 19. East-west fusion-necrosis and apoptosis acting in concert by demethylcantharidin-integrated platinum complexes.
    Pang SK, So WK, Ho YP, Au-Yeung CF.
    Anticancer Agents Med Chem; 2014 Jun 01; 14(5):756-61. PubMed ID: 24476313
    [Abstract] [Full Text] [Related]

  • 20. EXAFS and IR structural study of platinum-based anticancer drugs' degradation by diethyl dithiocarbamate.
    Bouvet D, Michalowicz A, Crauste-Manciet S, Brossard D, Provost K.
    Inorg Chem; 2006 Apr 17; 45(8):3393-8. PubMed ID: 16602799
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.